- Raw materials
- Alkalinizing agents
- Ammonium carbonate
Ammonium carbonate API Manufacturers & Suppliers
0 verified results
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Commercial-scale Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Ammonium carbonate | CAS No: 506-87-6 | GMP-certified suppliers
A medication that serves as an alkalizing agent and ionic source in pharmaceutical formulations, supporting pH balance and physicochemical stability in various medicinal products.
Therapeutic categories
Product Snapshot
- Ammonium carbonate is available as syrup, liquid, and solution formulations for nasal, respiratory inhalation, and oral administration routes
- It is primarily used for respiratory indications requiring expectorant or mucolytic effects
- The product is approved for use in the Canadian market with experimental status noted
Clinical Overview
Pharmacologically, ammonium carbonate does not possess a defined mechanism of action in therapeutic use. It functions primarily as an alkalizing agent and a source of carbonate and ammonium ions, which can influence pH and ionic balance in formulations. Its role is often auxiliary rather than therapeutic, contributing to the physicochemical properties of medicinal products rather than exerting direct pharmacodynamic effects.
Absorption, distribution, metabolism, and excretion (ADME) characteristics are not typically applicable or well-characterized for ammonium carbonate as an API since it is seldom used as a systemic agent. Upon administration, ammonium carbonate may dissociate into ammonia, carbon dioxide, and water, depending on the medium and conditions, which underlines its volatile and reactive nature.
From a safety perspective, ammonium carbonate must be handled with caution due to the potential for irritation upon inhalation or contact, and the release of ammonia gas under certain conditions may pose respiratory hazards. Its toxicity profile is generally considered low when used appropriately, but bulk handling and formulation require adherence to occupational safety standards.
Notable pharmaceutical usage contexts include its function as a leavening agent or excipient in some traditional or specialized medicinal products, but it is not a common API in modern therapeutic regimens.
For sourcing and quality control, procurement of ammonium carbonate APIs should prioritize compliance with pharmacopeial standards, such as USP or EP, ensuring high purity and absence of contaminants that could impact product safety or efficacy. Analytical verification of identity, assay, and residual solvents is essential to meet regulatory requirements. Stability testing and appropriate handling guidelines should be established due to the compound’s volatility and hygroscopic properties.
Identification & chemistry
| Generic name | Ammonium carbonate |
|---|---|
| Molecule type | Small molecule |
| CAS | 506-87-6 |
| UNII | PDP691CN28 |
| DrugBank ID | DB15926 |
Formulation & handling
- Ammonium carbonate is a small molecule suitable for oral and nasal/respiratory inhalation routes, available as syrups and solutions.
- High water solubility facilitates formulation in liquid dosage forms but may require attention to solution stability over time.
- No peptide or biologic properties present, minimizing sensitivity to food and enzymatic degradation concerns.
Regulatory status
| Lifecycle | The API's primary patents have expired, allowing for generic entry in the Canadian market. As a result, the product is in the mature phase of its lifecycle with established market presence and multiple competitor offerings. |
|---|
| Markets | Canada |
|---|
Supply Chain
| Supply chain summary | The supply landscape for ammonium carbonate in Canada includes originator companies producing branded formulations such as Bronchozone Cough Syrup Certified and Esprit D'ammoniaque Aromatique. These branded products primarily serve the Canadian market, with limited global presence reported. Patent expiry status indicates that generic competition is likely established or imminent, suggesting a mature market environment. |
|---|
Ammonium carbonate is a type of Alkalinizing agents
Alkalinizing agents, a pharmaceutical API category, refers to a group of substances used to increase the pH (alkalinity) of a solution or body fluid. These agents play a crucial role in various medical applications, such as the treatment of acidosis, kidney disorders, and certain drug overdoses.
One commonly used alkalinizing agent is sodium bicarbonate, which is highly effective in raising the pH of blood and urine. It works by neutralizing excess acid and restoring the acid-base balance in the body. Sodium bicarbonate is often administered intravenously in emergency situations to rapidly correct severe acidosis.
Another alkalinizing agent, acetazolamide, is frequently employed in the treatment of glaucoma and certain types of epilepsy. By inhibiting carbonic anhydrase, acetazolamide reduces the production of bicarbonate ions, leading to a systemic decrease in pH. This mechanism is particularly useful in lowering the intraocular pressure associated with glaucoma.
Alkalinizing agents are also utilized in the management of certain drug toxicities. For instance, methotrexate, a chemotherapy medication, can cause severe toxicity if its elimination is hindered. Alkalinizing the urine with agents like sodium bicarbonate enhances methotrexate solubility, preventing the formation of toxic crystals in the kidneys.
In conclusion, alkalinizing agents are indispensable pharmaceutical APIs that help correct acid-base imbalances, treat specific medical conditions, and mitigate drug toxicities. Their diverse applications make them valuable tools in modern medicine.
